Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Target identified with potential to overcome cancer drug resistance
University of Queensland researchers have identified a novel drug target with the potential to overcome…
Cancer vaccine shows promise for multiple myeloma in small trial
A dendritic cell vaccine administered before and after autologous stem cell transplant (ASCT) was safe…
Exercise may reduce cancer risk for lynch syndrome patients
Regular and intense aerobic exercise may reduce the risk of colorectal cancer in patients with…
AI is transforming medicine – but it can only work with proper sharing of data
Ara Darzi, Imperial College London It is not often that one witnesses a transformational advance in medicine. But the application…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.